ClinicalTrials.govpublic full text
Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
type 1 diabetes, diabetes mellitus, type 1, insulin, closed-loop system, glp-1 receptor agonist, semaglutide, artificial pancreas, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896241
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.